Monitoring of Hematoporphyrin Injected in Humans and Clinical Prospects of its Use in Gynecologic Oncology
The use of hematoporphyrin (HP) and its water soluble derivatives (HPD) as tumor localizers1 and sensitizers for phototherapy of neoplasias 2 is well documented and receiving rapidly increasing interest.
KeywordsGynecologic Oncology Clinical Prospect Darkened Light Normal Surrounding Tissue Hematoporphyrin Derivative
Unable to display preview. Download preview PDF.
- 1.D. A. Cortese, J. H. Kinsey, L. B. Woolner, W. S. Payne, D. R. Sanderson, and R. S. Fontana, Clinical application of a new endoscopic technique for detection of in situ bronchial carcinoma, Mayo Clin. Proc. 54: 635 (1979).Google Scholar
- 3.G. Jori, G. B. Pizzi, E. Reddi, L. Tomio, B. Salvato, P. L. Zorat, and F. Calzavara, Time-course of hematoporphyrin distribution in selected tissuesof normal rats and in ascites hepatoma, Tumori 65: 43 (1979).Google Scholar
- 5.I. Cozzani and J. D. Spikes, Photodamage and photokilling of malignant human cells in vitro by hematoporphyrin-visible light: molecular basis and possible mechanisms of photocyto-toxicity, Med. Biol. Environ. 10: 271 (1982).Google Scholar
- 6.L. Tomio, P. L. Zorat, G. Jori, E. Reddi, B. Salvato, L. Corti, and F. Calzavara, Elimination pathway of hematoporphyrin from normal and tumor-bearing rats, Tumori 68: 283 (1982).Google Scholar